Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India

Overview

Journal Tuberc Res Treat

Publisher Wiley

Specialty Infectious Diseases

Date 2012 Sep 12

PMID 22966426

Citations 37

Authors

Gerardo Alvarez-Uria

Jose M Azcona

Manoranjan Midde

Praveen K Naik

Srinivasulu Reddy

Raghuprakash Reddy

Affiliations

Soon will be listed here.

Abstract

HIV-related tuberculosis is difficult to diagnose and is associated with high morbidity and mortality. Recently, the World Health Organization has endorsed the GeneXpert MTB/RIF (Xpert) assay for the diagnosis of pulmonary tuberculosis in HIV-infected patients from developing countries, but information about the use of Xpert for the diagnosis of extrapulmonary tuberculosis is scarce. In this study, we compared the performance of light-emitting diode (LED) auramine fluorescent microscopy and the Xpert assay for the diagnosis of tuberculosis in HIV infected patients in a district hospital of India. Although at higher cost, Xpert outperformed LED fluorescent microscopy in all type of specimens, especially in cerebrospinal fluid where the number of positive results was increased 11 times. Pleural fluid, ascitic fluid, pus, and stool specimens also yielded positive results with the Xpert assay. When collecting two additional early-morning sputum samples, the increase of the number of positive results with the Xpert assay was lower than previously reported for HIV infected patients. Rifampicin resistance was observed in 2.2% of the cases. The results of this study show that the Xpert assay can dramatically improve the rapid diagnosis of tuberculous meningitis and other types of extrapulmonary tuberculosis of HIV infected patients.

Citing Articles

Tuberculosis in Cirrhosis - A Diagnostic and Management Conundrum.

Mishra S, Taneja S, De A, Muthu V, Verma N, Premkumar M J Clin Exp Hepatol. 2022; 12(2):278-286.

PMID: 35535073 PMC: 9077226. DOI: 10.1016/j.jceh.2021.09.003.

Tuberculosis-Specific Antigen/Phytohemagglutinin Ratio Combined With GeneXpert MTB/RIF for Early Diagnosis of Spinal Tuberculosis: A Prospective Cohort Study.

Qi Y, Liu Z, Liu X, Fang Z, Liu Y, Li F Front Cell Infect Microbiol. 2022; 12:781315.

PMID: 35174105 PMC: 8842995. DOI: 10.3389/fcimb.2022.781315.

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger C Cochrane Database Syst Rev. 2021; 1:CD012768.

PMID: 33448348 PMC: 8078545. DOI: 10.1002/14651858.CD012768.pub3.

Rifampicin-Resistant Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia.

Araya S, Negesso A, Tamir Z Infect Drug Resist. 2020; 13:3451-3459.

PMID: 33116664 PMC: 7547769. DOI: 10.2147/IDR.S263023.

Trends of and rifampicin resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia.

Abay G, Abraha B Trop Dis Travel Med Vaccines. 2020; 6:14.

PMID: 32874668 PMC: 7455993. DOI: 10.1186/s40794-020-00115-1.

References

Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K . Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2009; 48(1):229-37. PMC: 2812290. DOI: 10.1128/JCM.01463-09. View

Getahun H, Harrington M, OBrien R, Nunn P . Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007; 369(9578):2042-2049. DOI: 10.1016/S0140-6736(07)60284-0. View

Van Deun A, Hamid Salim A, Cooreman E, Daru P, Das A, Aung K . Scanty AFB smears: what's in a name?. Int J Tuberc Lung Dis. 2004; 8(7):816-23. View

Golden M, Vikram H . Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005; 72(9):1761-8. View

Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J . British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009; 59(3):167-87. DOI: 10.1016/j.jinf.2009.06.011. View

Kourbatova E, Leonard Jr M, Romero J, Kraft C, Del Rio C, Blumberg H . Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US. Eur J Epidemiol. 2006; 21(9):715-21. DOI: 10.1007/s10654-006-9060-7. View

Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, Pascarella M . Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J. 2012; 40(2):442-7. DOI: 10.1183/09031936.00176311. View

Small P, Pai M . Tuberculosis diagnosis--time for a game change. N Engl J Med. 2010; 363(11):1070-1. DOI: 10.1056/NEJMe1008496. View

Lawn S, Brooks S, Kranzer K, Nicol M, Whitelaw A, Vogt M . Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med. 2011; 8(7):e1001067. PMC: 3144215. DOI: 10.1371/journal.pmed.1001067. View

10.

Marais B, Brittle W, Painczyk K, Hesseling A, Beyers N, Wasserman E . Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin Infect Dis. 2008; 47(2):203-7. DOI: 10.1086/589248. View

11.

Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C . Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?. J Clin Microbiol. 2011; 49(7):2540-5. PMC: 3147857. DOI: 10.1128/JCM.02319-10. View

12.

Parsons L, Somoskovi A, Gutierrez C, Lee E, Paramasivan C, Abimiku A . Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev. 2011; 24(2):314-50. PMC: 3122496. DOI: 10.1128/CMR.00059-10. View

13.

Lawson L, Yassin M, Ramsay A, Emenyonu N, Squire S, Cuevas L . Comparison of scanty AFB smears against culture in an area with high HIV prevalence. Int J Tuberc Lung Dis. 2005; 9(8):933-5. View

14.

Kaplan J, Benson C, Holmes K, Brooks J, Pau A, Masur H . Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009; 58(RR-4):1-207. View

15.

Alvarez-Uria G, Midde M, Pakam R, Naik P . Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India. Infect Dis Rep. 2014; 4(1):e19. PMC: 3892649. DOI: 10.4081/idr.2012.e19. View

16.

Whalen C, Horsburgh Jr C, Hom D, LaHart C, Simberkoff M, Ellner J . Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS. 1997; 11(4):455-60. DOI: 10.1097/00002030-199704000-00008. View

17.

Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S . HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. Int J Infect Dis. 2009; 13(6):722-9. DOI: 10.1016/j.ijid.2008.11.013. View

18.

Corbett E, Watt C, Walker N, Maher D, Williams B, Raviglione M . The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003; 163(9):1009-21. DOI: 10.1001/archinte.163.9.1009. View